|
1. Biologie
|
|
|
|
|
3.8 Prévention - Alimentation
|
|
|
|
|
4.12 Biopsies liquides
|
|
|
|
|
4.2 Dép., diag. & prono. - Génome
|
|
|
|
5.12.8 Immunothérapies - Economie
|
|
|
Unum IPO hits bottom of range, netting $62M for cell therapy cancer trials [FierceBiotech]
|
|
|
|
|
|
Unum
plans to spend about $20 million to finish a phase 1 trial of its lead
antibody-coupled T cell receptor, ACTR087, in combination with rituximab
in adults with relapsed or refractory B cell non-Hodgkin lymphoma (NHL)
That is the trial in which two patients died from drug-related adverse
events and a third died after suffering a severe case of cytokine
release syndrome linked to ACTR087.
|
|
|
|
|
|
|
5.2 Pharma
|
|
|
|
5.2.2 Pharma - Fusions & Acquisitions
|
|
|
|
5.2.3 Pharma - économie
|
|
|
|
5.3.4 Traitements - AMM (FDA, EMA,...)
|
|
|
|
|
|
5.5 ASCO
|
|
|
Precision Medicine: A Conversation with Dr. Bruce E. Johnson [ASCO]
|
|
|
|
|
|
Things
can be actionable—and one of the things that they consider actionable
is referral for a clinical trial—but what you really want to know about
is the agent against that particular driver. Is there enough information
that you could say that the person is likely to benefit from the
therapeutic intervention?
|
|
|
|
|
|
|
6.4 Médico-éco
|
|
|
|
6.7 DMP, Big Data & applis
|
|
|
|
6.7.2 Applis
|
|
|
|